CD79B and B-cell non-Hodgkin lymphoma: In conclusion, our observations regarding the heterogeneous surface expression of CD79b correlating with the intensity of the light chain expression in aggressive B-cell lymphomas align well with our existing comprehension of the role of the BCR complex in this particular subtype of lymphomas [36].